These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23983177)

  • 1. Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron.
    Vadhan-Raj S; Strauss W; Ford D; Bernard K; Boccia R; Li J; Allen LF
    Am J Hematol; 2014 Jan; 89(1):7-12. PubMed ID: 23983177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD.
    Macdougall IC; Strauss WE; McLaughlin J; Li Z; Dellanna F; Hertel J
    Clin J Am Soc Nephrol; 2014 Apr; 9(4):705-12. PubMed ID: 24458078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min.
    Auerbach M; Strauss W; Auerbach S; Rineer S; Bahrain H
    Am J Hematol; 2013 Nov; 88(11):944-7. PubMed ID: 23828252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
.
    Macdougall IC; Strauss WE; Dahl NV; Bernard K; Li Z
    Clin Nephrol; 2019 Apr; 91(4):237-245. PubMed ID: 30802204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy.
    Hetzel D; Strauss W; Bernard K; Li Z; Urboniene A; Allen LF
    Am J Hematol; 2014 Jun; 89(6):646-50. PubMed ID: 24639149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease.
    Lu M; Cohen MH; Rieves D; Pazdur R
    Am J Hematol; 2010 May; 85(5):315-9. PubMed ID: 20201089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients.
    Provenzano R; Schiller B; Rao M; Coyne D; Brenner L; Pereira BJ
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):386-93. PubMed ID: 19176796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness of ferumoxytol in hemodialysis patients at 3 dialysis chains in the United States over a 12-month period.
    Schiller B; Bhat P; Sharma A
    Clin Ther; 2014 Jan; 36(1):70-83. PubMed ID: 24315802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study.
    Vadhan-Raj S; Ford DC; Dahl NV; Bernard K; Li Z; Allen LF; Strauss WE
    Am J Hematol; 2016 Feb; 91(2):E3-5. PubMed ID: 26572233
    [No Abstract]   [Full Text] [Related]  

  • 10. The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale.
    Macdougall IC; Dahl NV; Bernard K; Li Z; Batycky A; Strauss WE
    BMC Nephrol; 2017 Apr; 18(1):117. PubMed ID: 28372549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous infusions of ferumoxytol compared to oral ferrous sulfate for the treatment of anemia in pregnancy: a randomized controlled trial.
    Awomolo AM; McWhirter A; Sadler LC; Coppola LM; Hill MG
    Am J Obstet Gynecol MFM; 2023 Sep; 5(9):101064. PubMed ID: 37348816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferumoxytol for treating iron deficiency anemia in CKD.
    Spinowitz BS; Kausz AT; Baptista J; Noble SD; Sothinathan R; Bernardo MV; Brenner L; Pereira BJ
    J Am Soc Nephrol; 2008 Aug; 19(8):1599-605. PubMed ID: 18525001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferumoxytol: a new intravenous iron preparation for the treatment of iron deficiency anemia in patients with chronic kidney disease.
    Schwenk MH
    Pharmacotherapy; 2010 Jan; 30(1):70-9. PubMed ID: 20030475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Ferumoxytol in Pediatric Patients With Iron Deficiency Anemia.
    Hassan N; Boville B; Reischmann D; Ndika A; Sterken D; Kovey K
    Ann Pharmacother; 2017 Jul; 51(7):548-554. PubMed ID: 28622742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
    Onken JE; Bregman DB; Harrington RA; Morris D; Acs P; Akright B; Barish C; Bhaskar BS; Smith-Nguyen GN; Butcher A; Koch TA; Goodnough LT
    Transfusion; 2014 Feb; 54(2):306-15. PubMed ID: 23772856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter study evaluating the effectiveness and safety of single-dose low molecular weight iron dextran vs single-dose ferumoxytol for the treatment of iron deficiency.
    Cohen J; Khudanyan A; Lu J; Wing J; Olson S; Deloughery T; Shatzel JJ
    Am J Hematol; 2020 Dec; 95(12):1572-1577. PubMed ID: 32918335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial.
    Adkinson NF; Strauss WE; Macdougall IC; Bernard KE; Auerbach M; Kaper RF; Chertow GM; Krop JS
    Am J Hematol; 2018 May; 93(5):683-690. PubMed ID: 29417614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.
    Birgegård G; Henry D; Glaspy J; Chopra R; Thomsen LL; Auerbach M
    Pharmacotherapy; 2016 Apr; 36(4):402-14. PubMed ID: 26927900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferumoxytol: a new era of iron deficiency anemia treatment for patients with chronic kidney disease.
    Kowalczyk M; Banach M; Rysz J
    J Nephrol; 2011; 24(6):717-22. PubMed ID: 21956770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal outcomes from a randomized controlled trial of maternal treatment of iron deficiency anemia with intravenous ferumoxytol vs oral ferrous sulfate.
    Awomolo AM; McWhirter A; Sadler LC; Coppola LM; Hill MG
    Am J Obstet Gynecol MFM; 2023 Sep; 5(9):101063. PubMed ID: 37348817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.